The Board of Directors of Pharmesis International Ltd. announced that resignation of Independent Non-Executive Director. In connection with this, Mr. Pu has resigned as an Independent Non-Executive Director with effect from July 1, 2016. Consequently, Mr. Pu also ceased as a member of Audit Committee, Remuneration Committee and Nominating Committee of the company.

The company also appointed Mr. Jiang Ercheng has been appointed as a Non-Independent Non-Executive Director and a Member of Audit and Remuneration Committee with effect from July 1, 2016. Mr. Wu Xuedan has relinquished his position as Chief Executive Officer and remains as Executive Director of the Company with effect from 1 July 2016 due to the reshuffling of the Board members and realignment of duties. Subsequent to Mr. Wu Xuedan resigning as CEO, Mr. Jiang Yun has been appointed as CEO with effect from 1 July 2016.

The re-designation of Mr. Jiang Yun from Executive Chairman to Executive Director; and the re-designation of Mr. Chew Heng Ching from Lead Independent Director to Independent Non-Executive Chairman.